A Hidden Reservoir of Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococcus in Patients Newly Admitted to an Acute Rehabilitation Hospital

PM and R

Volumn 4, Issue 1, 2012, Pages 18-22

  Rabinowitz, Ronald P ^a   Kufera, Joseph A ^a   Makley, Michael J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; COTRIMOXAZOLE; QUINOLONE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE SURVEILLANCE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PATIENT IDENTIFICATION; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; REHABILITATION CENTER; RISK FACTOR; VANCOMYCIN RESISTANT ENTEROCOCCUS; WINTER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BALTIMORE; CARRIER STATE; CROSS INFECTION; ENTEROCOCCUS; FEMALE; FOLLOW-UP STUDIES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; INFECTION CONTROL; INPATIENTS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PROSPECTIVE STUDIES; REHABILITATION CENTERS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE; YOUNG ADULT;

EID: 84856090062     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2011.09.011     Document Type: Article

References (28)

1. Boucher H.W., Talbot G.H., Bradley J.S., et al. Bad bugs, no drugs: No ESKAPE!. An update from the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1-12.
2. Howard D.H., Cordell R., McGowan J.E., et al. Measuring the economic costs of antimicrobial resistance in hospital settings: Summary of the Centers for Disease Control and Prevention-Emory Workshop. Clin Infect Dis 2001, 33:1573-1578.
3. Honda H., Krauss M.J., Coopersmith C.M., et al. Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: Does methicillin resistance matter?. Infect Control Hosp Epidemiol 2010, 31:584-591.
4. Asche C., McAdam-Marx C., Seal B., et al. Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance. J Antimicrob Chemother 2008, 61:1162-1168.
5. Kallen A.J., Mu Yi, Bulens S., et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010, 304:641-689.
6. Diekema D.J., BootsMiller B.J., Vaughn T.E., et al. Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis 2004, 38:78-85.
7. Siegel J.D., Rhinehart E.M., Jackson M., Chiarello L. Healthcare-associated Infections (HAI) The Healthcare Infection Control Practices Advisory Committee, Accessed November 5, 2011. http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf%20-%201-74.
8. Ramsey A.M., Zilberger M.D. Secular trends of hospitalization with vancomycin-resistant Enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol 2009, 30:184-186.
9. Hidron A.I., Edwards J.R., Patel J., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008, 29:996-1011.
10. Mylotte J.M., Graham R., Kahler L., et al. Epidemiology of nosocomial infection and resistant organisms in patients admitted for the first time to an acute rehabilitation unit. Clin Infect Dis 2000, 30:425-432.
11. Aeilts G.D., Sapico F.L., Canawati H.N., et al. Methicillin-resistant Staphylococcus aureus colonization and infection in a rehabilitation facility. J Clin Microbiol 1982, 16:218-223.
12. Manian F.A., Senkle D., Zack J., Meyer L. Routine screening for methicillin-resistant Staphylococcus aureus among patients newly admitted to an acute rehabilitation unit. Infect Control Hosp Epidemiol 2002, 23:516-519.
13. Strausbaugh L.J., Crossley K.B., Nurse B.A., et al. Antimicrobial resistance in long-term-care facilities. Infect Control Hosp Epidemiol 1996, 17:129-140.
14. Mylotte J.M., Kahler L., Graham R., et al. Prospective surveillance for antibiotic-resistant organisms in patients with spinal cord injury admitted to an acute rehabilitation unit. Am J Infect Control 2000, 28:291-297.
15. Diekema D.J., Edmond M.B. Look before you leap: Active surveillance for multidrug-resistant organisms. Clin Infect Dis 2007, 44:1101-1107.
16. Chang S., Sethi A.K., Stiefel U., et al. Occurrence of skin and environmental contamination with methicillin-resistant Staphylococcus aureus before results of polymerase chain reaction at hospital admission become available. Infect Control Hosp Epidemiol 2010, 31:607-612.
17. Chang S., Sethi A.K., Brittany C., et al. Skin and environmental contamination with methicillin-resistant Staphylococcus aureus among carriers identified clinically versus through active surveillance. Clin Infect Dis 2009, 48:1423-1428.
18. Duckro A.N., Blom D.W., Lyle E.A., et al. Transfer of vancomycin-resistant enterococci via health care worker hands. Arch Intern Med 2005, 165:302-307.
19. Shorr A.F. Epidemiology of staphylococcal resistance. Clin Infect Dis 2007, 45:S171-S176.
20. Safdar N., Maki D.G. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, gram-negative bacilli, Clostridium difficile, and candida. Ann Intern Med 2002, 136:834-844.
21. Rezende N.A., Blumberg H.M., Metzger B.S., et al. Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission. Am J Med Sci 2002, 323:117-123.
22. Graffunder E.M., Venezia R.A. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002, 49:999-1005.
23. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis 2007, 44:S27-S72.
24. Hall M.J., DeFrances C.J., Williams S.N., et al. National Hospital Discharge Survey: 2007 summary. Natl Health Stat Report 2010, 29:1-24.
25. Ottenbacher K.J., Smith P.M., Illig S.B., et al. Trends in length of stay, living setting, functional outcome, and mortality following medical rehabilitation. JAMA 2004, 292:1687-1695.
26. MRSA laws Association for Professionals in Infection Control and Epidemiology, Inc., Accessed November 5, 2011. http://www.apic.org/downloads/legislation/MRSA_map.gif.
27. Jain R., Kralovic S.M., Evans M.E., et al. Veterans Affairs Initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011, 364:1419-1430.
28. Huskins W.C., Huckabee C.M., O'Grady N.P., et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011, 364:1407-1418.